Nabriva Therapeutics AG Price to Sales Ratio 2015-2020 | NBRV

Historical PS ratio values for Nabriva Therapeutics AG (NBRV) over the last 10 years. The current P/S ratio for Nabriva Therapeutics AG as of December 02, 2020 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Nabriva Therapeutics AG P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2020-12-02 0.39 151.06
2020-09-30 0.53 $0.00 0.00
2020-06-30 0.67 $0.01 61.77
2020-03-31 0.58 $0.01 51.28
2019-12-31 1.32 $0.01 102.66
2019-09-30 2.00 $0.01 143.08
2019-06-30 2.43 $0.01 0.00
2019-03-31 2.44 $0.01 0.00
2018-12-31 1.46 $0.02 58.62
2018-09-30 2.70 $0.03 99.64
2018-06-30 3.48 $0.03 110.39
2018-03-31 5.03 $0.03 151.05
2017-12-31 5.98 $0.02 314.56
2017-09-30 8.19 $0.03 251.26
2017-06-30 10.48 $0.03 328.07
2017-03-31 12.00 $0.04 328.97
2016-12-31 5.96 $0.03 196.64
2016-09-30 7.05 $0.01 543.88
2016-06-30 7.50 $0.01 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.644B $0.009B
Nabriva Therapeutics is a biopharmaceutical company engaged in the research and development of new medicines to treat serious bacterial infections, with a focus on the pleuromutilin class of antibiotics. Nabriva Therapeutics' medicinal chemistry expertise has enabled targeted discovery of novel pleuromutilins, including both intravenous and oral formulations. Nabriva Therapeutics' lead product candidate, lefamulin, is a novel semi-synthetic pleuromutilin antibiotic with the potential to be the first-in-class available for systemic administration in humans. The company believes that lefamulin is the first antibiotic with a novel mechanism of action to have reached late-stage clinical development in more than a decade. Nabriva has announced positive topline data for lefamulin from the first of its two global, registrational Phase 3 clinical trials evaluating lefamulin in patients with moderate to severe community-acquired bacterial pneumonia (CABP).
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $141.192B 10.06
Amgen (AMGN) United States $129.265B 13.51
CSL (CSLLY) Australia $100.321B 0.00
Gilead Sciences (GILD) United States $76.052B 10.11
Moderna (MRNA) United States $60.441B 0.00
Vertex Pharmaceuticals (VRTX) United States $59.224B 27.54
Regeneron Pharmaceuticals (REGN) United States $55.064B 19.53
Illumina (ILMN) United States $47.025B 64.68
Biogen (BIIB) United States $36.958B 6.57
Seagen (SGEN) United States $30.708B 81.10
BioNTech SE (BNTX) Germany $28.111B 0.00
Alexion Pharmaceuticals (ALXN) United States $26.723B 10.65
Genmab (GMAB) Denmark $25.307B 29.93
Genmab (GNMSF) Denmark $23.353B 5.38
BeiGene (BGNE) Cayman Islands $23.216B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.638B 0.00
Incyte (INCY) United States $18.514B 0.00
Exact Sciences (EXAS) United States $18.210B 0.00
Bio-Rad Laboratories (BIO.B) United States $16.122B 61.14
Horizon Therapeutics Public (HZNP) Ireland $15.545B 22.22
Alnylam Pharmaceuticals (ALNY) United States $15.093B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.286B 94.82
ARGENX SE-ADR (ARGX) Netherlands $13.483B 0.00
Guardant Health (GH) United States $12.109B 0.00
Mirati Therapeutics (MRTX) United States $11.959B 0.00
Bio-Techne Corp (TECH) United States $11.711B 74.89
Sarepta Therapeutics (SRPT) United States $11.116B 0.00
QIAGEN (QGEN) Netherlands $10.991B 24.75
Repligen (RGEN) United States $9.980B 141.54
Ascendis Pharma (ASND) Denmark $9.013B 0.00
ACADIA Pharmaceuticals (ACAD) United States $9.008B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $8.967B 0.00
Novavax (NVAX) United States $8.881B 0.00
Galapagos (GLPG) Belgium $8.011B 0.00
Denali Therapeutics (DNLI) United States $7.311B 0.00
Ultragenyx Pharmaceutical (RARE) United States $7.236B 0.00
Acceleron Pharma (XLRN) United States $7.114B 0.00
Adaptive Biotechnologies (ADPT) United States $6.595B 0.00
Blueprint Medicines (BPMC) United States $6.023B 19.94
Amicus Therapeutics (FOLD) United States $5.965B 0.00
Exelixis (EXEL) United States $5.944B 39.92
SWEDISH ORP BIO (BIOVF) Sweden $5.355B 14.63
Halozyme Therapeutics (HALO) United States $5.286B 244.38
NeoGenomics (NEO) United States $5.283B 1586.00
Reata Pharmaceuticals (RETA) United States $5.175B 0.00
Fate Therapeutics (FATE) United States $5.101B 0.00
Twist Bioscience (TWST) United States $5.045B 0.00
China Biologic Products (CBPO) China $4.684B 30.35
Emergent Biosolutions (EBS) United States $4.342B 14.25
Vir Biotechnology (VIR) United States $4.061B 0.00
Insmed (INSM) United States $3.974B 0.00
Legend Biotech (LEGN) United States $3.842B 0.00
Arena Pharmaceuticals (ARNA) United States $3.831B 0.00
MorphoSys AG (MOR) Germany $3.682B 133.29
Eidos Therapeutics (EIDX) United States $3.559B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.518B 0.00
Bluebird Bio (BLUE) United States $2.926B 0.00
Alkermes (ALKS) Ireland $2.906B 28.53
Beam Therapeutics (BEAM) United States $2.898B 0.00
Global Blood Therapeutics (GBT) United States $2.837B 0.00
Seres Therapeutics (MCRB) United States $2.519B 0.00
Zymeworks (ZYME) Canada $2.413B 0.00
Intellia Therapeutics (NTLA) United States $2.320B 0.00
Alcobra (ARCT) United States $2.247B 0.00
I-Mab (IMAB) China $2.233B 0.00
PHARMA MAR SA (PHMMF) Spain $2.161B 0.00
Sorrento Therapeutics (SRNE) United States $2.156B 0.00
UniQure (QURE) Netherlands $2.139B 0.00
Viela Bio (VIE) United States $2.102B 0.00
Inovio Pharmaceuticals (INO) United States $2.070B 0.00
Amarin (AMRN) Ireland $1.940B 0.00
Editas Medicine (EDIT) United States $1.907B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.896B 0.00
Intra-Cellular Therapies (ITCI) United States $1.895B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.800B 0.00
Mesoblast (MESO) Australia $1.770B 0.00
Arcus Biosciences (RCUS) United States $1.768B 0.00
Mersana Therapeutics (MRSN) United States $1.745B 0.00
Scholar Rock Holding (SRRK) United States $1.676B 0.00
NGM Biopharmaceuticals (NGM) United States $1.636B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.607B 13.30
Revance Therapeutics (RVNC) United States $1.607B 0.00
Zealand Pharma (ZEAL) Denmark $1.533B 0.00
Precigen (PGEN) United States $1.469B 0.00
Sangamo Therapeutics (SGMO) United States $1.413B 0.00
Epizyme (EPZM) United States $1.396B 0.00
Ligand Pharmaceuticals (LGND) United States $1.357B 35.15
Coherus BioSciences (CHRS) United States $1.330B 8.79
Adverum Biotechnologies (ADVM) United States $1.325B 0.00
Myriad Genetics (MYGN) United States $1.319B 0.00
REGENXBIO (RGNX) United States $1.303B 0.00
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Athenex (ATNX) United States $1.272B 0.00
Genetron Holdings (GTH) China $1.209B 0.00
Cytokineticsorporated (CYTK) United States $1.189B 0.00
Heska (HSKA) United States $1.182B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.172B 0.00
Travere Therapeutics (TVTX) United States $1.171B 0.00
Vericel (VCEL) United States $1.160B 0.00
Northwest Biotherapeutics (NWBO) United States $1.145B 0.00
Codexis (CDXS) United States $1.098B 0.00
Cellectis S.A (CLLS) France $1.078B 0.00
NantKwest (NK) United States $1.040B 0.00
Alector (ALEC) United States $1.039B 0.00
Arvinas (ARVN) United States $0.981B 0.00
Pliant Therapeutics (PLRX) United States $0.976B 0.00
Morphic Holding (MORF) United States $0.976B 0.00
Frequency Therapeutics (FREQ) United States $0.968B 0.00
Castle Biosciences (CSTL) United States $0.947B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.947B 0.00
Protagonist Therapeutics (PTGX) United States $0.924B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.903B 0.00
Celldex Therapeutics (CLDX) United States $0.890B 0.00
Pharming Group (PHGUF) Netherlands $0.889B 20.29
Compugen (CGEN) Israel $0.879B 0.00
Cardiff Oncology (CRDF) United States $0.873B 0.00
VBI Vaccines (VBIV) United States $0.829B 0.00
Kadmon Holdings (KDMN) United States $0.748B 0.00
MiMedx (MDXG) United States $0.745B 0.00
Cara Therapeutics (CARA) United States $0.731B 0.00
Five Prime Therapeutics (FPRX) United States $0.715B 0.00
Albireo Pharma (ALBO) United States $0.710B 0.00
AnaptysBio (ANAB) United States $0.705B 0.00
Agenus (AGEN) United States $0.704B 0.00
MannKind (MNKD) United States $0.693B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.668B 33.92
Sutro Biopharma (STRO) United States $0.660B 0.00
Precision BioSciences (DTIL) United States $0.654B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.652B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.638B 0.00
IVERIC Bio (ISEE) United States $0.611B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.600B 0.00
Geron (GERN) United States $0.579B 0.00
Dynavax Technologies (DVAX) United States $0.560B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.548B 0.00
MeiraGTx Holdings (MGTX) United States $0.542B 0.00
Anika Therapeutics (ANIK) United States $0.537B 72.69
Aquinox Pharmaceuticals (NLTX) United States $0.532B 0.00
Avid Bioservices (CDMO) United States $0.516B 0.00
Merus (MRUS) Netherlands $0.498B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.493B 0.00
Cel-Sci (CVM) United States $0.483B 0.00
Prothena (PRTA) Ireland $0.452B 0.00
Forte Biosciences (FBRX) United States $0.451B 0.00
Spero Therapeutics (SPRO) United States $0.451B 0.00
Puma Biotechnology (PBYI) United States $0.447B 0.00
Clovis Oncology (CLVS) United States $0.435B 0.00
UROGEN PHARMA (URGN) United States $0.434B 0.00
WAVE Life Sciences (WVE) Singapore $0.430B 0.00
Amryt Pharma (AMYT) United Kingdom $0.429B 0.00
Cue Biopharma (CUE) United States $0.423B 0.00
Innate Pharma S.A (IPHA) France $0.422B 0.00
Kala Pharmaceuticals (KALA) United States $0.418B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.416B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.410B 0.00
Affimed (AFMD) Germany $0.407B 0.00
AC Immune SA (ACIU) Switzerland $0.397B 0.00
Trevena (TRVN) United States $0.394B 0.00
Starpharma Holdings (SPHRY) Australia $0.387B 0.00
Arbutus Biopharma (ABUS) United States $0.385B 0.00
BioDelivery Sciences (BDSI) United States $0.384B 18.09
Bicycle Therapeutics (BCYC) United Kingdom $0.378B 0.00
Syros Pharmaceuticals (SYRS) United States $0.373B 0.00
Athersys (ATHX) United States $0.366B 0.00
ANI Pharmaceuticals (ANIP) United States $0.365B 9.30
XOMA (XOMA) United States $0.365B 0.00
Selecta Biosciences (SELB) United States $0.363B 0.00
Cellular Biomedicine (CBMG) United States $0.358B 0.00
CytomX Therapeutics (CTMX) United States $0.348B 0.00
Verastem (VSTM) United States $0.341B 0.00
ChromaDex (CDXC) United States $0.306B 0.00
Kamada (KMDA) Israel $0.302B 14.13
CorMedix Inc (CRMD) United States $0.289B 0.00
PDL BioPharma (PDLI) United States $0.289B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.283B 0.00
NextCure (NXTC) United States $0.279B 0.00
IBio (IBIO) United States $0.271B 0.00
DBV Technologies S.A (DBVT) France $0.269B 0.00
AquaBounty Technologies (AQB) United States $0.261B 0.00
Pluristem Therapeutics (PSTI) Israel $0.259B 0.00
Fortress Biotech (FBIO) United States $0.258B 0.00
HOOKIPA Pharma (HOOK) United States $0.253B 0.00
Aptinyx (APTX) United States $0.251B 0.00
TELA Bio (TELA) United States $0.236B 0.00
Nicox SA (NICXF) France $0.216B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.214B 0.00
GENFIT S.A (GNFT) France $0.208B 0.00
ADMA Biologics Inc (ADMA) United States $0.193B 0.00
Eton Pharmaceuticals (ETON) United States $0.192B 0.00
Bellus Health (BLU) Canada $0.190B 0.00
Cerecor (CERC) United States $0.187B 0.00
Strongbridge Biopharma (SBBP) United States $0.186B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Aptevo Therapeutics (APVO) United States $0.181B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.180B 0.00
Theratechnologies (THTX) Canada $0.177B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.163B 0.00
Checkpoint Therapeutics (CKPT) United States $0.163B 0.00
Dyadic (DYAI) United States $0.161B 0.00
Biofrontera AG (BFRA) Germany $0.161B 0.00
SESEN BIO, INC (SESN) United States $0.160B 0.00
Abeona Therapeutics (ABEO) United States $0.160B 0.00
VolitionRX (VNRX) United States $0.158B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.155B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.155B 0.00
VTv Therapeutics (VTVT) United States $0.154B 0.00
Kindred Biosciences (KIN) United States $0.153B 0.00
Oncobiologics (OTLK) United States $0.153B 0.00
Cocrystal Pharma (COCP) United States $0.148B 0.00
Idera Pharmaceuticals (IDRA) United States $0.146B 0.00
TRACON Pharmaceuticals (TCON) United States $0.137B 0.00
Catalyst Biosciences (CBIO) United States $0.137B 0.00
Celyad SA (CYAD) Belgium $0.137B 0.00
Exicure (XCUR) United States $0.136B 0.00
Lumos Pharma (LUMO) United States $0.125B 0.00
Protalix BioTherapeutics (PLX) Israel $0.120B 0.00
Orgenesis (ORGS) United States $0.117B 243.00
Gritstone Oncology (GRTS) United States $0.115B 0.00
Applied Genetic Technologies (AGTC) United States $0.115B 0.00
Aytu Bioscience (AYTU) United States $0.113B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.112B 0.00
Cogent Biosciences (COGT) United States $0.111B 0.00
Windtree Therapeutics (WINT) United States $0.111B 0.00
Liquidia Technologies (LQDA) United States $0.105B 0.00
DiaMedica Therapeutics (DMAC) United States $0.105B 0.00
Cyclerion Therapeutics (CYCN) United States $0.105B 0.00
Enzo Biochem (ENZ) United States $0.104B 0.00
Cidara Therapeutics (CDTX) United States $0.103B 0.00
Palatin Technologies (PTN) United States $0.101B 0.00
Clearside Biomedical (CLSD) United States $0.097B 0.00
Novogen (KZIA) Australia $0.095B 0.00
Prometic Life Sciences (LMNL) Canada $0.094B 0.00
ARAVIVE, INC (ARAV) United States $0.093B 0.00
AIT Therapeutics (XAIR) United States $0.093B 0.00
Evogene (EVGN) Israel $0.089B 0.00
Ecology Coatings (ABVC) United States $0.087B 0.00
Curis (CRIS) United States $0.085B 0.00
Synlogic (SYBX) United States $0.082B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.081B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.078B 0.00
Prima BioMed (IMMP) Australia $0.077B 0.00
Bionano Genomics (BNGO) United States $0.075B 0.00
Stealth BioTherapeutics (MITO) United States $0.071B 34.00
MiRagen Therapeutics (MGEN) United States $0.069B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Soligenix (SNGX) United States $0.068B 0.00
Adocia (ADOCY) France $0.067B 0.00
AnPac Bio-Medical Science (ANPC) China $0.064B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.063B 0.00
Armata Pharmaceuticals (ARMP) United States $0.059B 0.00
Appili Therapeutics (APLIF) Canada $0.059B 0.00
Organovo Holdings (ONVO) United States $0.058B 0.00
Emmaus Life Sciences (EMMA) United States $0.056B 0.00
Proteostasis Therapeutics (PTI) United States $0.055B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.055B 0.00
Vascular Biogenics (VBLT) Israel $0.055B 0.00
Seelos Therapeutics (SEEL) United States $0.052B 0.00
Happiness Biotech Group (HAPP) China $0.051B 0.00
Edesa Biotech (EDSA) Canada $0.049B 0.00
Pulmatrix (PULM) United States $0.047B 0.00
Vaccinex (VCNX) United States $0.047B 0.00
CollPlant Holdings (CLGN) Israel $0.045B 0.00
ATyr Pharma (LIFE) United States $0.044B 0.00
Genetic Technologies (GENE) Australia $0.043B 0.00
Cleveland BioLabs (CBLI) United States $0.042B 0.00
IMMURON (IMRN) Australia $0.040B 0.00
Chanticleer Holdings (SONN) United States $0.036B 0.00
OvaScience (MLND) United States $0.035B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.034B 0.00
Titan Pharmaceuticals (TTNP) United States $0.033B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.033B 0.00
Acorda Therapeutics (ACOR) United States $0.032B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Celsion (CLSN) United States $0.025B 0.00
AEterna Zentaris (AEZS) United States $0.025B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Prana Biotechnology (ATHE) Australia $0.022B 0.00
Spherix (AIKI) United States $0.020B 0.00
Advaxis (ADXS) United States $0.020B 0.00
Cesca Therapeutics (THMO) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.019B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
BioPharmX (TMBR) United States $0.013B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00